Ongoing reference literature on BWFI
Br J Cancer 75 : 251257 D'Ambrosio C, Ferber A, Resnicoff M, Baserga R (1996) A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis
control, 1307)
In most of the lawsuits, courts have entered preliminary injunction orders that include statements like the following: Use of Novo Nordisks registered trademarks OZEMPIC, WEGOVY, and/or RYBELSUS, in connection with compounded drugs purporting to contain semaglutide or in connection with the advertising, marketing, sale, or promotion of such drugs is likely to cause confusion and infringe Novo Nordisks trademark rights
This includes dose flexibility, a broader range of medication options, and integrated lifestyle tools